Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

Vietnam flag Vietnam · Delayed Price · Currency is VND
24,800
+1,000 (4.20%)
At close: Mar 5, 2026
161.05%
Market Cap 124.00B
Revenue (ttm) 148.87B
Net Income (ttm) 16.90B
Shares Out 5.00M
EPS (ttm) 3,380.00
PE Ratio 7.34
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,601
Average Volume 5,886
Open 23,000
Previous Close 23,800
Day's Range 23,000 - 24,800
52-Week Range 8,100 - 26,400
Beta 0.78
RSI 69.09
Earnings Date Apr 20, 2026

About HNX:MKV

Cai Lay Veterinary Pharmaceutical Joint Stock Company produces and trades in veterinary medicines in Vietnam and Indochina. The company offers Mekosal, a product for cattle, pets, fish, poultry, swine, and other animals through distributors and sales agents. It also engages in the production of premix, nutrients, and animal feed for livestock, poultry, and aquaculture; fishing for aquatic products and seafood; production, processing, and manufacturing of agricultural products; wholesale of fertilizers and plant seeds; breeding marine aquatic pr... [Read more]

Industry Pharmaceutical Preparations
Founded 2003
Employees 104
Stock Exchange Hanoi Stock Exchange
Ticker Symbol MKV
Full Company Profile

Financial Performance

In 2025, HNX:MKV's revenue was 148.87 billion, an increase of 39.08% compared to the previous year's 107.04 billion. Earnings were 16.90 billion, an increase of 130.75%.

Financial Statements

News

There is no news available yet.